Biopact

biopact is a nanoscale biomaterials company developing the xact™ intracellular delivery vehicle. xact is a cellular-engineering tool for biomanufacturing and agricultural processes which value efficient delivery of rnas, peptides and genetic materials. xact™ is a highly-efficient intracellular delivery vehicle, consisting of a stabile dispersion of hollow, nanoscale tubules approximately 1/10,000th the width of a human hair. the high aspect-ratio, nanoscale profile of xact allows it to readily penetrate cells without compromising membrane integrity or inducing cytotoxicity. its high surface-to-volume ratio and tunable surface chemistry allow it to readily transport both small and large-molecular payloads into the cytoplasm, including growth factors, oligonucleotides, proteins and gene-editing complexes. biopact has evaluated the cytotoxicity profile of xact across multiple cell-lines and investigated safety and efficacy in murine biodistribution and clearance models. our in vivo studie